THE EFFECTIVENESS OF COMBINED ORAL LYSINE ACETYLSALICYLATE AND METOCLOPRAMIDE COMPARED WITH ORAL SUMATRIPTAN FOR MIGRAINE

被引:164
作者
TFELTHANSEN, P
HENRY, P
MULDER, LJ
SCHELDEWAERT, RG
SCHOENEN, E
CHAZOT, G
机构
[1] PELLEGRIN TRIOPODE HOSP,BORDEAUX,FRANCE
[2] IKAZIA HOSP,ROTTERDAM,NETHERLANDS
[3] SYNTHELABO RES,LE PLESSIS ROBINS,FRANCE
[4] CITADELLE HOSP,LIEGE,BELGIUM
[5] NEUROL HOSP,LYON,FRANCE
来源
LANCET | 1995年 / 346卷 / 8980期
关键词
D O I
10.1016/S0140-6736(95)91554-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive treatment, is also effective. We compared a combination of lysine acetylsalicylate (equivalent to 900 mg aspirin) and 10 mg metoclopramide (LAS+MTC) with oral sumatriptan (100 mg) and placebo in 421 patients with migraine. LAS+MTC was as effective as sumatriptan with a decrease of headache from severe or moderate to mild or none of 57% and 53%, respectively, for the first migraine attack treated. Both treatments were better than placebo (success rate 24%, p<0.0001). LAS+MTC was significantly more effective in the treatment of nausea than sumatriptan (p<0.0001) and was better tolerated (adverse events in 18% and 28%, respectively, p<0.05). LAS+MTC is as effective as sumatriptan in the treatment of migraine attacks. It is also much cheaper.
引用
收藏
页码:923 / 926
页数:4
相关论文
共 11 条
[1]   THE SAFETY AND TOLERABILITY OF SUMATRIPTAN - AN OVERVIEW [J].
BROWN, EG ;
ENDERSBY, CA ;
SMITH, RN ;
TALBOT, JCC .
EUROPEAN NEUROLOGY, 1991, 31 (05) :339-344
[2]   COMBINED ORAL LYSINE ACETYLSALICYLATE AND METOCLOPRAMIDE IN THE ACUTE TREATMENT OF MIGRAINE - A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY [J].
CHABRIAT, H ;
JOIRE, JE ;
DANCHOT, J ;
GRIPPON, P ;
BOUSSER, MG .
CEPHALALGIA, 1994, 14 (04) :297-300
[3]   CARDIOVASCULAR ADVERSE REACTIONS TO SUMATRIPTAN - CAUSE FOR CONCERN [J].
OTTERVANGER, JP ;
STRICKER, BHC .
CNS DRUGS, 1995, 3 (02) :90-98
[4]  
Simmons VE, 1994, REV CONTEMP PHARMACO, V5, P319
[5]   SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE ATTACKS - A REVIEW OF CONTROLLED CLINICAL-TRIALS [J].
TFELTHANSEN, P .
CEPHALALGIA, 1993, 13 (04) :238-244
[6]   ABSORPTION OF EFFERVESCENT ASPIRIN DURING MIGRAINE [J].
VOLANS, GN .
BRITISH MEDICAL JOURNAL, 1974, 4 (5939) :265-268
[7]   EFFECT OF METOCLOPRAMIDE ON ABSORPTION OF EFFERVESCENT ASPIRIN IN MIGRAINE [J].
VOLANS, GN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (01) :57-63
[8]   TREATMENT OF THE ACUTE MIGRAINE ATTACK - CURRENT STATUS [J].
WILKINSON, M .
CEPHALALGIA, 1983, 3 (01) :61-67
[9]  
1991, EUR NEUROL, V31, P314
[10]  
1992, EUR NEUROL, V32, P177